2004 Cannabinoids Patients THC 
Project CBD
JULY 2, 2018
Many of our patients have called in asking about cannabinoid hyperemesis syndrome ( CHS ), as this syndrome has been reported in the media numerous times over the past few months. This is a very rare syndrome that occurs in long-term heavy users of THC -rich cannabis. CHS was first reported in the medical literature in 2004.
United Patients Group
FEBRUARY 22, 2023
The symptoms can be so severe that some patients require hospitalization for dehydration. It’s more likely to occur in people who use high doses of cannabis, most often reported with THC. appeared first on United Patients Group. The condition develops after frequent and long-term use of cannabis.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
OCTOBER 19, 2022
Medical marijuana is not technically legal, but cannabinoid-based medications are. The same year, the government reclassified cannabinoids to make them available for medical use. Still, officially the market is only 18 years old, as the country joined the EU in 2004, and thus fell into compliance with EU hemp regulations.
Greencamp
FEBRUARY 17, 2019
The stress response in IBS patients causes abnormalities in the functioning of the sympathetic nervous system (one of the divisions of the autonomic or “subconscious” nervous system) and to the HPA axis. We produce endocannabinoids—internal cannabinoid-like compounds, that bind to these cellular endocannabinoid receptors.
Otherside Farms
JANUARY 23, 2019
DCA – Cancer Cure Discovered – But YOU can’t have it… THC (marijuana) Helps Cure Cancer Says Harvard Study. Differential effects of repeated low dose treatment with the cannabinoid agonist WIN 55,212-2 in experimental models of bone cancer pain and neuropathic pain. Proof that Marijuana may cure cancer.
The Cannigma
OCTOBER 20, 2021
Since 2011, cannabis products that contain up to 1% THC are legal in Switzerland, leading to a growing market in “Cannabis Light” products. The pilot schemes will be limited to one municipality each, and can provide cannabis with up to 20% THC to a maximum of 5,000 registered participants at approved points of sale.
Greencamp
FEBRUARY 2, 2019
Even though cannabis and cannabinoid-derived pharmaceuticals are both frequently used by HIV/AIDS patients, several studies show that something interesting happens when cannabis is consumed. Cannabis as a palliative aid for HIV patients. What is HIV and how is it manifested? How classical pharmaceuticals fight HIV.
Expert insights. Personalized for you.
223 
Let's personalize your content